Profile data is unavailable for this security.
About the company
Glycorex Transplantation AB (publ) is a Sweden-based medical device company engaged in the research, development, production and sales of medical devices within the field of organ transplantation. The Company's main product, Glycosorb-ABO, facilitates organ transplantation between different blood types. Additionally, the Company has developed complementary product variants, such as Glycosorb-ABO A/B-kolonn, designed for different patient categories, and Glycosorb-Xeno, which can facilitate transplants between animals and humans. The Company’s medical devices enable transplants across the blood groups saving lives and providing health economic benefits by increasing the number of transplants.
- Revenue in SEK (TTM)38.84m
- Net income in SEK-7.72m
- Incorporated1995
- Employees20.00
- LocationGlycorex Transplantation AB (publ)Scheelevagen 27LUND 223 63SwedenSWE
- Phone+46 462865230
- Fax+46 462865239
- Websitehttps://glycorex.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lifecare ASA | 6.32m | -113.85m | 73.71m | 24.00 | -- | -- | -- | 11.66 | -2.29 | -2.29 | 0.1299 | -- | -- | -- | -- | 276,625.00 | -- | -72.46 | -- | -98.80 | -- | -- | -1,810.66 | -492.21 | -- | -- | -- | -- | -31.34 | 4.26 | -66.57 | -- | -- | -- |
| Spago Nanomedical AB (publ) | 437.00k | -26.55m | 76.41m | 7.00 | -- | 2.49 | -- | 174.86 | -0.0513 | -0.0513 | 0.0008 | 0.0465 | 0.0115 | -- | 4.39 | 62,428.57 | -69.64 | -30.44 | -81.41 | -32.48 | -- | -- | -6,076.43 | -3,410.33 | -- | -- | -- | -- | -77.13 | 5.02 | 18.32 | -- | -- | -- |
| Opsy Holding AB | 6.69m | -7.86m | 80.63m | 7.00 | -- | 52.25 | -- | 12.05 | -8.55 | -8.55 | 0.705 | 0.1215 | 0.8126 | -- | 9.41 | 955,857.10 | -95.38 | -129.63 | -199.92 | -161.05 | 144.70 | -- | -117.38 | -2,431.63 | -- | -69.76 | 0.435 | -- | -- | -- | 62.94 | -- | 43.17 | -- |
| IDL Diagnostics AB (publ) | 53.13m | -31.76m | 80.63m | 22.00 | -- | 0.5442 | -- | 1.52 | -0.1379 | -0.1379 | 0.2306 | 0.6432 | 0.3417 | 5.69 | 5.03 | -- | -20.43 | -25.11 | -22.66 | -27.00 | 33.53 | 14.91 | -59.78 | -110.47 | 2.83 | -- | 0.082 | -- | -7.54 | 263.23 | 71.38 | -- | -- | -- |
| Biovica International AB | 9.86m | -76.47m | 80.75m | 24.00 | -- | 0.6861 | -- | 8.19 | -0.6375 | -0.6375 | 0.0684 | 0.4241 | 0.0799 | 12.71 | 4.46 | 365,333.30 | -61.92 | -58.22 | -70.41 | -66.49 | -171.53 | -462.09 | -775.22 | -1,804.16 | 8.11 | -- | 0.0239 | -- | 18.23 | 38.83 | 29.80 | -- | -47.26 | -- |
| Biosergen AB | 0.00 | -40.82m | 86.88m | 1.00 | -- | -- | -- | -- | -17.68 | -17.68 | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -112.64 | -- | -- | -- |
| Coegin Pharma AB | 79.00k | -20.50m | 93.29m | 3.00 | -- | 19.67 | -- | 1,180.89 | -0.824 | -0.824 | 0.0032 | 0.1907 | 0.0039 | -- | 2.16 | -- | -101.52 | -113.82 | -136.64 | -160.62 | -974.68 | -- | -25,945.57 | -170,432.90 | -- | -681.70 | -- | -- | -- | -- | 13.81 | -- | -- | -- |
| Alzinova AB | 205.00k | -26.88m | 94.98m | 5.00 | -- | 0.4643 | -- | 463.30 | -0.2846 | -0.2846 | 0.0022 | 1.23 | 0.0015 | -- | 0.3254 | 41,000.00 | -19.42 | -12.21 | -20.69 | -12.85 | -5,834.15 | -- | -13,114.15 | -21,390.81 | -- | -1,794.80 | 0.0062 | -- | -88.89 | -- | -24.71 | -- | 19.48 | -- |
| Alligator Bioscience AB | 514.00k | -51.35m | 98.67m | 13.00 | -- | 1.18 | -- | 191.97 | -1.09 | -1.09 | 0.0074 | 0.1566 | 0.0048 | -- | 1.98 | -- | -47.78 | -101.41 | -- | -222.85 | -- | -- | -9,990.27 | -526.56 | -- | -- | 0.8354 | -- | -99.11 | -34.77 | 78.05 | -- | 70.30 | -- |
| Annexin Pharmaceuticals AB (publ) | 0.00 | -36.89m | 101.65m | 4.00 | -- | 4.08 | -- | -- | -5.98 | -5.98 | 0.00 | 3.53 | 0.00 | -- | -- | 0.00 | -150.00 | -137.53 | -190.93 | -169.50 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 26.58 | -- | -- | -- |
| Exact Therapeutics AS | 0.00 | -68.77m | 104.85m | 12.00 | -- | 1.63 | -- | -- | -1.40 | -1.40 | 0.00 | 1.07 | 0.00 | -- | -- | 0.00 | -108.82 | -43.50 | -168.39 | -50.76 | -- | -- | -- | -- | -- | -20.18 | 0.0052 | -- | -- | -- | -8.27 | -- | 1.47 | -- |
| Glycorex Transplantation AB (publ) | 38.84m | -7.72m | 105.82m | 20.00 | -- | 3.20 | 67.19 | 2.72 | -0.0983 | -0.0983 | 0.4952 | 0.438 | 0.7685 | 1.35 | 6.37 | 1,942,200.00 | -15.27 | -17.65 | -20.85 | -21.45 | 82.84 | 85.42 | -19.87 | -41.50 | 1.35 | -16.24 | 0.1682 | -- | 10.48 | 7.55 | 29.44 | -- | -37.57 | -- |
| Abera Bioscience AB | 0.00 | -10.45m | 111.78m | 5.00 | -- | 5.80 | -- | -- | -0.5692 | -0.5692 | 0.00 | 1.04 | 0.00 | -- | -- | -- | -49.58 | -63.36 | -74.82 | -81.05 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -850.27 | -- | -- | -- |
| Active Biotech AB publ | 0.00 | -37.30m | 116.51m | 5.00 | -- | 2.10 | -- | -- | -0.0236 | -0.0236 | 0.00 | 0.0211 | 0.00 | -- | -- | 0.00 | -65.79 | -93.70 | -82.91 | -119.51 | -- | -- | -- | -- | -- | -- | 0.0018 | -- | -- | -- | 5.33 | -- | -- | -- |
| Xbrane Biopharma AB | 152.35m | -46.17m | 121.55m | 29.00 | -- | 0.2168 | -- | 0.7978 | -106.73 | 1,665.76 | 29.07 | 27.21 | 0.2013 | 0.2847 | 12.91 | 5,253,586.00 | -6.10 | -25.02 | -10.00 | -43.04 | 58.77 | -- | -30.30 | -144.31 | 3.43 | -1.80 | 0.0942 | -- | 2.87 | -- | 67.33 | -- | 105.02 | -- |
| NextCell Pharma AB | 10.94m | -35.14m | 141.02m | 24.00 | -- | 2.12 | -- | 12.89 | -0.4414 | -0.4414 | 0.133 | 0.596 | 0.1384 | 51.23 | 4.68 | -- | -44.48 | -34.95 | -49.25 | -37.53 | -155.37 | -266.34 | -321.31 | -427.08 | 9.92 | -- | -- | -- | 2.56 | 25.13 | 16.25 | -- | 36.88 | -- |
Data as of Mar 09 2026. Currency figures normalised to Glycorex Transplantation AB (publ)'s reporting currency: Swedish Krona SEK
1.97%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Skandia Fonder ABas of 30 Dec 2024 | 1.49m | 1.97% |
Data from 28 Nov 2025 - 28 Nov 2025Source: FactSet Research Systems Inc.
